In a filing, Avadel Pharmaceuticals plc revealed its Director Palczuk Linda acquired Company’s shares for reported $39640.0 on Jan 21 ’25. In the deal valued at $7.93 per share,5,000 shares were bought. As a result of this transaction, Palczuk Linda now holds 67,900 shares worth roughly $0.57 million.
Then, Thornton Peter J. bought 10,000 shares, generating $80,450 in total proceeds. Upon buying the shares at $8.04, the Director now owns 104,055 shares.
Before that, Ende Eric J bought 30,000 shares. Avadel Pharmaceuticals plc shares valued at $235,218 were divested by the Director at a price of $7.84 per share. As a result of the transaction, Ende Eric J now holds 208,900 shares, worth roughly $1.76 million.
Deutsche Bank initiated its Avadel Pharmaceuticals plc [AVDL] rating to a Buy in a research note published on February 11, 2025; the price target was $12. A number of analysts have revised their coverage, including Rodman & Renshaw’s analysts, who began to cover the stock in mid June with a ‘”a Buy”‘ rating. Oppenheimer also remained covering AVDL and reiterated its “an Outperform” recommendation on March 05, 2024. Needham maintained its rating on March 05, 2024. It rated AVDL as “a Buy”.
Price Performance Review of AVDL
On Friday, Avadel Pharmaceuticals plc [NASDAQ:AVDL] saw its stock fall -0.71% to $8.41. Over the last five days, the stock has lost -6.45%. Avadel Pharmaceuticals plc shares have fallen nearly -19.98% since the year began. Nevertheless, the stocks have fallen -34.60% over the past one year. While a 52-week high of $19.09 was reached on 01/03/25, a 52-week low of $7.39 was recorded on 01/10/25. SMA at 50 days reached $9.15, while 200 days put it at $13.19.
Levels Of Support And Resistance For AVDL Stock
The 24-hour chart illustrates a support level at 8.24, which if violated will result in even more drops to 8.07. On the upside, there is a resistance level at 8.70. A further resistance level may holdings at 8.98. The Relative Strength Index (RSI) on the 14-day chart is 45.86, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.07, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 56.71%. Stochastics %K at 47.01% indicates the stock is a holding.
The most recent change occurred on March 05, 2024 when H.C. Wainwright resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $25.
